Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis

• Main Authors: Alberto Gajofatto, Valeria Donisi, Isolde Martina Busch, Francesca Gobbin, Elena Butturini, Massimiliano Calabrese, Alessandra Carcereri de Prati, Paola Cesari, Lidia Del Piccolo, Massimo Donadelli, Paolo Fabene, Stefania Fochi, Macarena Gomez-Lira, Roberta Magliozzi, Giovanni Malerba, Raffaella Mariotti, Sofia Mariotto, Chiara Milanese, Maria Grazia Romanelli, Andrea Sbarbati, Federico Schena, Maria Angela Mazzi, Michela Rimondini
• Format: Article
• Language: English
• Published: BMJ Publishing Group 2019-08-01
• Series: BMJ Open
• Online Access: https://bmjopen.bmj.com/content/9/8/e030469.full

IntroductionMultiple sclerosis (MS), the most common neurological disease causing disability in young adults, is widely recognised as a major stress factor. Studies have shown that the first years after the diagnosis are distressing in terms of adjustment to the disease and that MS negatively affects patients’ psychological well-being, quality of life (QoL) and social functioning. However, the links between disease-specific variables at diagnosis, resilience and psychological adjustment of patients with MS remain largely unexplored, especially in adolescents and young adults. This observational study aims to fill the gap of knowledge on biopsychosocial characteristics and resilience of young adults with MS to evaluate the relationship among these variables and to develop a biopsychosocial model of resilience.Methods and analysisBiological and clinical characteristics of young adults newly diagnosed with MS will be investigated by collecting clinical information, performing neurological examinations, MRI and analysing cerebrospinal fluid and blood biomarkers (eg, measures of inflammation), body composition, gut microbiota and movement/perceptual markers. Psychosocial characteristics (eg, psychological distress, coping strategies), QoL, psychological well-being and resilience will be assessed by self-report questionnaires. Comparative statistics (ie, analysis of variance or unpaired samples t-test, correlation and regression analyses) will be applied to evaluate the relationship among biological, psychological and social factors. The results are expected to allow a comprehensive understanding of the determinants of resilience in young patients with MS and to inform resilience interventions, tailored to young patients’ specific needs, aiming to reduce the risk of maladaptive reactions to the disease and to improve psychological well-being and QoL.Ethics and disseminationThe study has been approved by the Verona University Hospital Ethics Committee (approval number: 2029CESC). The findings will be disseminated through scientific publications in peer-reviewed journals, conference presentations, social media and specific websites.Trial registration numberClinicalTrials.gov (NCT03825055).